Cartesian Therapeutics, Inc. Logo

Cartesian Therapeutics, Inc.

A clinical-stage company developing mRNA-engineered cell therapies for autoimmune diseases.

RNAC | US

Overview

Corporate Details

ISIN(s):
US8162121045
LEI:
Country:
United States of America
Address:
7495 NEW HORIZON WAY, 21703 FREDERICK

Description

Cartesian Therapeutics, Inc. is a clinical-stage company that pioneers the development of mRNA-engineered cell therapies. The company's primary focus is on creating treatments for autoimmune diseases. Leveraging its novel mRNA technology platform, Cartesian develops therapeutic cells designed to target the drivers of these conditions. This approach aims to expand the reach and potential of cell therapy for patients with various autoimmune disorders. The company's lead asset, Descartes-08, is a central component of its clinical pipeline.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-07-05 22:02
FORM 4
English ZIP 7.3 KB
2024-07-03 22:10
FORM 4
English ZIP 7.4 KB
2024-07-03 22:07
FORM 3
English ZIP 655.2 KB
2024-07-02 12:30
8-K
English ZIP 7.4 MB
2024-06-17 13:54
8-K
English ZIP 72.2 KB
2024-05-22 13:08
8-K
English ZIP 293.2 KB
2024-05-10 16:03 English ZIP 9.7 KB
2024-05-08 13:06
10-Q
English ZIP 2.1 MB
2024-05-08 13:03
8-K
English ZIP 6.0 MB
2024-04-26 15:09
DEF 14A
English ZIP 3.0 MB
2024-04-26 13:57
DEFA14A
English ZIP 1.2 MB
2024-04-22 12:25
8-K
English ZIP 67.0 KB
2024-04-19 22:49
FORM 3
English ZIP 598.9 KB
2024-04-12 22:24
AMENDMENT NO. 13 TO SCHEDULE 13D
English ZIP 15.4 KB
2024-04-11 03:47
FORM 4
English ZIP 9.6 KB

Automate Your Workflow. Get a real-time feed of all Cartesian Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cartesian Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cartesian Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.